OptimizeRx Corporation Common Stock (OPRX)
OptimizeRx Corporation (OPRX) is a digital health company that provides a platform connecting healthcare providers and pharmaceutical companies. It delivers real-time, point-of-care communication solutions aimed at improving patient outcomes by streamlining the delivery of medication information, reimbursement support, and adherence programs within the healthcare ecosystem.
Company News
OptimizeRx Corp. has received a purported notice of nominations from a stockholder, Whetstone Capital Advisors, LLC, regarding its intention to nominate two candidates for election to the OptimizeRx Board of Directors at the Company's 2025 Annual Meeting of Stockholders.
Smith Micro Software, Inc. reported a Q2 loss of $0.38 per share, missing the Zacks Consensus Estimate of a loss of $0.35. The company's revenue of $5.14 million also missed estimates. The stock has lost about 62.9% since the beginning of the year.
OptimizeRx (NASDAQ:OPRX) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Ind...
Previous periods of low valuations have resulted in big comebacks for smaller companies.
OPRX earnings call for the period ending June 30, 2022.